Examples of using Lenalidomide in English and their translations into Italian
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
-
Official/political
It is not known whether the effect will be different in the therapeutic situation higher lenalidomide doses and concomitant treatment with dexamethasone.
Grade 3-4 infections were noted in 28% and 24.3% of Empliciti combined with lenalidomide and dexamethasone and lenalidomide and dexamethasone treated patients, respectively.
you must follow the pregnancy prevention programme for lenalidomide see package leaflet for lenalidomide. .
Solid tumours were reported in 2.5% and 1.9% of Empliciti combined with lenalidomide and dexamethasone and lenalidomide and dexamethasone treated patients, respectively.
Table 4: Exposure-adjusted rates for adverse reactions for Empliciti-treated patients versus lenalidomide and dexamethasone-treated patients includes multiple occurrences of all treated patients.
The boxes containing Revlimid capsules also include a warning stating that lenalidomide is expected to be harmful to the unborn child.
The results of the blood tests may necessitate an interruption of the therapy or a reduction of the Lenalidomide dose.
Currently available pharmacokinetic data are described in section 5.2. Lenalidomide has been used in clinical trials in multiple myeloma patients up to 91 years of age
Lenalidomide treatment must not be started if the Absolute Neutrophil Counts(ANC)<
For patients older than 75 years of age treated with lenalidomide in combination with dexamethasone,
In mantle cell lymphoma patients, lenalidomide is associated with a higher incidence of grade 3
Treatment with Kyprolis combined with lenalidomide and dexamethasone for longer than 18 cycles should be based on an individual benefit-risk assessment,
The efficacy and safety of lenalidomide were evaluated in two Phase III multi-centre, randomised, double- blind, placebo-controlled, parallel-group controlled studies(MM-009 and MM-010) of lenalidomide plus dexamethasone therapy versus dexamethasone alone in previously treated patients with multiple myeloma.
In a clinical trial of patients with multiple myeloma(Study 1), deep vein thromboses were reported in 7.2% of patients treated with Empliciti combined with lenalidomide and dexamethasone(N 318) and 3.8% of patients treated with lenalidomide and dexamethasone N 317.
patients with multiple myeloma(Study 1), invasive SPMs have been observed in 6.9% of patients treated with Empliciti combined with lenalidomide and dexamethasone(N 318) and 4.1% of patients treated with lenalidomide and dexamethasone N 317.
The safety data of elotuzumab have been assessed from a total of 554 patients with multiple myeloma treated with elotuzumab in combination with lenalidomide and dexamethasone(451 patients)
prednisone and lenalidomide followed by lenalidomide maintenance(MPR+R) or melphalan, prednisone and lenalidomide followed by placebo(MPR+p)
examples of the corticosteroid medications used include lenalidomide and thalidomide.
Patients randomized to the lenalidomide/low dose dexamethasone arm received lenalidomide 25 mg/day, Days 1 to
There is no specific experience in the management of lenalidomide over dose in multiple myeloma patients,